index - CRCL-Résistance hormonale, méthylation et cancer du sein

Sébastien Martinez, Stéphanie Sentis, Coralie Poulard, Olivier Trédan, Muriel Le Romancer. Role of PRMT1 and PRMT5 in Breast Cancer. International Journal of Molecular Sciences, 2024, 25, ⟨10.3390/ijms25168854⟩. ⟨hal-04765663⟩
Isabelle L Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, Marie-Ange Mouret-Reynier, Olfa Derbel, et al.. Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial. Nature Communications, 2024, 15 (1), pp.5931. ⟨10.1038/s41467-024-46999-x⟩. ⟨hal-04765682⟩
Loïc Verlingue, Marine Desevre, Marie Polito, Gwenaelle Garin, Christine Rodriguez, et al.. The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST. Acta Oncologica, 2024, 63, pp.411 - 417. ⟨10.2340/1651-226x.2024.32745⟩. ⟨hal-04765764⟩
Gilles Freyer, Anne Floquet, Olivier Trédan, Aurore Carrot, Carole Langlois-Jacques, et al.. Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group. Nature Communications, 2024, 15 (1), pp.1985. ⟨10.1038/s41467-024-45974-w⟩. ⟨hal-04549309⟩
Panagiotis Tsimpos, Simon Desiderio, Pauline Cabochette, Philippe Poelvoorde, Sadia Kricha, et al.. Loss of G9a does not phenocopy the requirement for Prdm12 in the development of the nociceptive neuron lineage. Neural Development, 2024, 19, pp.1. ⟨10.1186/s13064-023-00179-7⟩. ⟨hal-04481763⟩
Alexandre Casanova, Gael Roth, Simone Hausmann, Xiaoyin Lu, Ludivine Bischoff, et al.. Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis. Cell Discovery, 2024, 10 (1), pp.12. ⟨10.1038/s41421-023-00644-x⟩. ⟨hal-04245506⟩

Derniers manuscrits de l'équipe

Chiffres clés